Quantitative determination of captopril, perindopril erbumine, moexipril hydrochloride, and ramipril in bulk and pharmaceutical preparations by high performance liquid chromatography | ||||
| Records of Pharmaceutical and Biomedical Sciences | ||||
| Article 4, Volume 1, Issue 1, March 2017, Page 22-32 PDF (868.48 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/rpbs.2018.5917 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Mohamed Elgawish  1; Samia M. Mostafa2; Abdalla A. Elshanawane3
| ||||
| 1Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia, 41522, Egypt. | ||||
| 2Medicinal Chemistry Department, Faculty of Pharmacy, University of Suez Canal, Ismailia 41522, Egypt | ||||
| 3Medicinal Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt | ||||
| Abstract | ||||
| A high-performance liquid chromatographic method was developed for simultaneous determination of four ACE-inhibitors: captopril (CAP), perindopril erbumine (PER), moexipril hydrochloride (MOEX), and ramipril (RAM) in pharmaceutical formulations. The chromatographic separation was performed on Shim-pack cyanopropyl column with a mobile phase consisting of methanol-10mM ammonium acetate buffer (pH 6.0) in a ratio of (40: 60, v/v) at flow rate 1 ml min-1. the analysis was performed at ambient temperature using UV detector setting at 210 nm. All ACE-inhibitors were separated within seven min. The calibration curves were linear (r ≥ 0.9994) over a concentration range from 5 to 50 µg ml-1. the method was successfully applied to commercially available pharmaceutical preparations. The validity of the method was examined comparing the results obtained with official or published methods. | ||||
| Keywords | ||||
| Column liquid chromatography; ACE-Inhibitors; Pharmaceutical formulations | ||||
|
Statistics Article View: 367 PDF Download: 431 |
||||
